MedTrace Logo

Estimating Length of Endotracheal Tube Insertion Using Gestational Age or Nasal-Tragus Length in Newborn Infants

NCT04393337 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 454

Last updated 2021-10-25

No results posted yet for this study

Summary

Endotracheal intubation is a life-saving intervention that few infants need after birth. Although an endotracheal tube is the most reliable way of providing positive-pressure breath, the critical factor that determines the maximal efficacy of positive-pressure ventilation is the optimal placement of the endotracheal tube tip. There are various methods available to determine the initial depth of endotracheal tube (ETT) that are based on the infant's birth weight, gestational age, anthropometric measurements, and others include vocal cord guide and suprasternal palpation methods.

The Neonatal Resuscitation Program (NRP) textbook, in its 7th edition of the textbook, recommends a gestational age chart and nasal-tragus length method for estimating endotracheal tube insertion depth during cardiopulmonary resuscitation of the neonate. The evidence to support these two methods is, however, limited. Hence, we designed this study to determine the accuracy of two methods, gestational age chart and nasal-tragus length method, recommended by the Neonatal Resuscitation Program.

Conditions

  • Endotracheal Tube Tip Position
  • Bronchopulmonary Dysplasia
  • Pneumothorax
  • Death
  • Duration, Ventilator

Interventions

OTHER

Gestational Age Chart Method

The endotracheal tube insertion depth is obtained by the gestational age chart

OTHER

Nasal-Tragus Length Method

The endotracheal tube insertion depth is obtained by the nasal-tragus method formula

Sponsors & Collaborators

  • King Fahad Hospital

    collaborator UNKNOWN

  • King Faisal Specialist Hospital & Research Center

    collaborator OTHER

  • Princess Nourah Bint Abdulrahman University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04393337 on ClinicalTrials.gov